DYADIC INTERNATIONAL INC (DYAI) Fundamental Analysis & Valuation

NASDAQ:DYAI • US26745T1016

0.7676 USD
+0.01 (+0.99%)
At close: Mar 6, 2026
0.755 USD
-0.01 (-1.64%)
After Hours: 3/6/2026, 8:13:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This DYAI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Overall DYAI gets a fundamental rating of 2 out of 10. We evaluated DYAI against 520 industry peers in the Biotechnology industry. DYAI may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, DYAI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. DYAI Profitability Analysis

1.1 Basic Checks

  • In the past year DYAI has reported negative net income.
  • In the past year DYAI has reported a negative cash flow from operations.
  • In the past 5 years DYAI always reported negative net income.
  • In the past 5 years DYAI always reported negative operating cash flow.
DYAI Yearly Net Income VS EBIT VS OCF VS FCFDYAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

  • The Return On Assets of DYAI (-62.95%) is worse than 60.00% of its industry peers.
  • DYAI has a worse Return On Equity (-281.84%) than 71.73% of its industry peers.
Industry RankSector Rank
ROA -62.95%
ROE -281.84%
ROIC N/A
ROA(3y)-70.74%
ROA(5y)-60.92%
ROE(3y)-146.19%
ROE(5y)-108.49%
ROIC(3y)N/A
ROIC(5y)N/A
DYAI Yearly ROA, ROE, ROICDYAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

  • The Gross Margin of DYAI (31.54%) is better than 73.08% of its industry peers.
  • DYAI's Gross Margin has improved in the last couple of years.
  • DYAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y50.87%
GM growth 5Y38.12%
DYAI Yearly Profit, Operating, Gross MarginsDYAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. DYAI Health Analysis

2.1 Basic Checks

  • DYAI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DYAI has more shares outstanding
  • DYAI has a worse debt/assets ratio than last year.
DYAI Yearly Shares OutstandingDYAI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DYAI Yearly Total Debt VS Total AssetsDYAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of -10.16, we must say that DYAI is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -10.16, DYAI is doing worse than 72.31% of the companies in the same industry.
  • DYAI has a Debt/Equity ratio of 1.92. This is a high value indicating a heavy dependency on external financing.
  • DYAI's Debt to Equity ratio of 1.92 is on the low side compared to the rest of the industry. DYAI is outperformed by 78.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Altman-Z -10.16
ROIC/WACCN/A
WACCN/A
DYAI Yearly LT Debt VS Equity VS FCFDYAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

  • A Current Ratio of 2.85 indicates that DYAI has no problem at all paying its short term obligations.
  • With a Current ratio value of 2.85, DYAI is not doing good in the industry: 65.77% of the companies in the same industry are doing better.
  • A Quick Ratio of 2.85 indicates that DYAI has no problem at all paying its short term obligations.
  • DYAI's Quick ratio of 2.85 is on the low side compared to the rest of the industry. DYAI is outperformed by 63.65% of its industry peers.
Industry RankSector Rank
Current Ratio 2.85
Quick Ratio 2.85
DYAI Yearly Current Assets VS Current LiabilitesDYAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DYAI Growth Analysis

3.1 Past

  • DYAI shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.35%.
  • The Revenue has decreased by -0.66% in the past year.
  • Measured over the past years, DYAI shows a quite strong growth in Revenue. The Revenue has been growing by 15.78% on average per year.
EPS 1Y (TTM)-4.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y13.35%
Revenue growth 5Y15.78%
Sales Q2Q%-40.47%

3.2 Future

  • DYAI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -229.27% yearly.
  • The Revenue is expected to grow by 58.83% on average over the next years. This is a very strong growth
EPS Next Y-14.75%
EPS Next 2Y21.02%
EPS Next 3Y-229.27%
EPS Next 5YN/A
Revenue Next Year-10.33%
Revenue Next 2Y31.23%
Revenue Next 3Y17.64%
Revenue Next 5Y58.83%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DYAI Yearly Revenue VS EstimatesDYAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M
DYAI Yearly EPS VS EstimatesDYAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

0

4. DYAI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DYAI. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DYAI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DYAI Price Earnings VS Forward Price EarningsDYAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DYAI Per share dataDYAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2

4.3 Compensation for Growth

  • A cheap valuation may be justified as DYAI's earnings are expected to decrease with -229.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.02%
EPS Next 3Y-229.27%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DYAI Dividend Analysis

5.1 Amount

  • DYAI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DYAI Fundamentals: All Metrics, Ratios and Statistics

DYADIC INTERNATIONAL INC

NASDAQ:DYAI (3/6/2026, 8:13:03 PM)

After market: 0.755 -0.01 (-1.64%)

0.7676

+0.01 (+0.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)03-24
Inst Owners17.12%
Inst Owner Change-5.1%
Ins Owners14.79%
Ins Owner Change2.64%
Market Cap27.78M
Revenue(TTM)3.34M
Net Income(TTM)-7.35M
Analysts82.86
Price Target7.14 (830.17%)
Short Float %0.41%
Short Ratio1.99
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.9%
Min EPS beat(2)-35.76%
Max EPS beat(2)1.96%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)30.92%
Min Revenue beat(2)3.83%
Max Revenue beat(2)58.01%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.31
P/FCF N/A
P/OCF N/A
P/B 10.65
P/tB 10.65
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0.09
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -62.95%
ROE -281.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.54%
FCFM N/A
ROA(3y)-70.74%
ROA(5y)-60.92%
ROE(3y)-146.19%
ROE(5y)-108.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y50.87%
GM growth 5Y38.12%
F-Score2
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.85
Quick Ratio 2.85
Altman-Z -10.16
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
EPS Next Y-14.75%
EPS Next 2Y21.02%
EPS Next 3Y-229.27%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y13.35%
Revenue growth 5Y15.78%
Sales Q2Q%-40.47%
Revenue Next Year-10.33%
Revenue Next 2Y31.23%
Revenue Next 3Y17.64%
Revenue Next 5Y58.83%
EBIT growth 1Y-9.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.12%
OCF growth 3YN/A
OCF growth 5YN/A

DYADIC INTERNATIONAL INC / DYAI FAQ

What is the ChartMill fundamental rating of DYADIC INTERNATIONAL INC (DYAI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to DYAI.


Can you provide the valuation status for DYADIC INTERNATIONAL INC?

ChartMill assigns a valuation rating of 0 / 10 to DYADIC INTERNATIONAL INC (DYAI). This can be considered as Overvalued.


What is the profitability of DYAI stock?

DYADIC INTERNATIONAL INC (DYAI) has a profitability rating of 1 / 10.